Article

Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma

Clinical Practice Unit, The Queen Elizabeth Hospital, Adelaide, Australia.
Cochrane database of systematic reviews (Online) (Impact Factor: 5.7). 12/2012; 12(12):1-51. DOI: 10.1002/14651858.CD004360.pub4
Source: PubMed

ABSTRACT Asthma is a chronic respiratory condition causing inflammation and changes to the airways. Care of people with asthma includes routine and urgent management across primary and tertiary care; however, due to sub-optimal long-term care and delays in obtaining help during acute exacerbations, the mortality and morbidity related to asthma is still a major health concern. There is reason to believe that non-invasive positive pressure ventilation (NPPV) could be beneficial to patients with severe acute asthma; however, the evidence surrounding the efficacy of NPPV is unclear, despite its common use in clinical practice.
To determine the efficacy of NPPV in adults with severe acute asthma in comparison to usual medical care with respect to mortality, tracheal intubation, changes in blood gases and hospital length of stay.
We carried out a search in the Cochrane Airways Group Specialised Register of trials (July 2012). Following this, the bibliographies of included studies and review articles were searched for additional studies (July 2012).
We included randomised controlled trials of adults with severe acute asthma as the primary reason for presentation to the emergency department or for admission to hospital. Asthma diagnosis was defined by internationally accepted criteria. Studies were included if the intervention was usual medical care for the management of severe acute asthma plus NPPV applied through a nasal or facemask compared to usual medical care alone. Studies including patients with features of chronic obstructive pulmonary disease (COPD) were excluded unless data were provided separately for patients with asthma in studies recruiting both COPD and asthmatic patients.
A combination of two review authors independently assessed trial quality and extracted data. Study authors were contacted for additional information where required. All data were analysed using RevMan 5.1. For continuous variables, a mean difference and 95% confidence interval were used and for dichotomous variables, risk ratio with 95% confidence interval were calculated.
We identified six trials for inclusion. Five studies on 206 participants contributed data, while one study was available in abstract form only and was not fully incorporated into this review. For the primary outcome of endotracheal intubation there were two studies that contributed data: two intubations were needed in 45 participants on NPPV and no intubations in 41 control patients (risk ratio 4.48; 95% CI 0.23 to 89.13). There were no deaths in either of these studies. Length of hospital stay was reported in two studies, though meta-analysis was not possible. Hospitalisation was reported in one small study, in which there were three admissions out of 17 on NPPV and 10 admissions out of 16 in control patients (RR 0.28, 95% CI 0.09, 0.84).
This review of studies has highlighted the paucity of data that exist to support the use of NPPV in patients in status asthmaticus. As such this course of treatment remains controversial despite its continued use in current clinical practice. Larger, prospective randomised controlled trials of rigorous methodological design are needed to determine the role of NPPV in patients with asthma.

Download full-text

Full-text

Available from: Kristin Carson, Aug 03, 2015
0 Followers
 · 
127 Views
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: RESUMEN La ventilación mecánica puede ser necesaria en cualquiera de las dos formas fundamentales de presentación del asma grave: hiperaguda y subaguda refractaria al tratamiento médico. Las referencias sobre la utilidad de la ventilación no invasiva en el asma bronquial con riesgo vital son escasas, y no se han realizado estudios a gran escala que definan la utilidad de este recurso en dicha patología, comparando distintas modalidades, como CPAP y BiPAP, y analizando los factores que influyen en el paciente asmático respecto a la aceptación y la tolerancia de la interfase. La implementación de las guías de práctica clínica del asma ha conllevado importantes reducciones en la morbimortalidad por esta enfermedad en las últimas décadas. A pesar de la alta prevalencia del asma, actualmente el número de fallecimientos debidos a una crisis asmática es relativamente bajo pero, aun así, representa una causa significativa de muerte inesperada que puede afectar a pacientes de cualquier edad, hecho más frecuente cuanto mayor es la severidad de la enfermedad . A partir de los datos de la historia clínica, se puede cla-sificar a los pacientes con un riesgo aumentado de falle-cer a causa del asma en dos grupos distintos. Un grupo está constituido por individuos que sufren un deterioro severo fulminante de la función de la vía respiratoria (brit-tle asthma), y el otro por sujetos con crisis de asma de larga duración. El mayor número de muertes por asma (80-85%) se produce en los pacientes con un asma se-vera y mal controlada, que se deterioran gradualmente en un plazo de días o semanas. En una pequeña proporción de pacientes, la muerte por asma puede ser súbita, sin antecedentes obvios de un deterioro prolongado de su control. Estos casos aparecen tras la exposición a alérgenos o irritantes, estrés, inhalación de drogas ilícitas o empleo de agentes antiinflamatorios no esteroides o bloqueado-res beta en pacientes susceptibles. En estas situaciones, junto con un tratamiento médico adecuado y precoz, en algunos casos es necesario plan-tear la ventilación mecánica. Ésta tiene sentido una vez que la musculatura respiratoria es incapaz de mantener la demanda ventilatoria y el paciente se va deteriorando progresivamente. El objetivo de la ventilación mecánica es proporcionar descanso a la musculatura respiratoria del enfermo hasta que comience a tratarse la causa de la exacerbación y se revierta la obstrucción bronquial. A este respecto, las guías sobre el manejo de las agudi-zaciones asmáticas graves y la recomendación de utilizar ventilación mecánica invasiva (VMI) o no invasiva (VMNI) no resultan aclaratorias. Por una aparte, la GINA 2 indica que en este aspecto es recomendable consultar otros tex-tos especializados, mientras que la GEMA 3 señala lo si-guiente: «(...) En caso de persistencia de insuficiencia res-piratoria refractaria o síntomas o signos de exacerbación grave a pesar del tratamiento, existe la posibilidad de uti-lizar VMNI o remitir al paciente a la unidad de cuidados intensivos (UCI) para recibir intubación orotraqueal y ventilación mecánica. Los estudios realizados hasta el momento con VMNI son escasos. La decisión de intubar al pacien-te se basará en el juicio clínico, cuando exista un deterioro progresivo o una claudicación de los músculos respiratorios. El modo de ventilación mediante hipercapnia permisiva ha demostrado mejores resultados que las modalida-des habituales de ventilación» (nivel de evidencia D). Debido a la escasa información al respecto en la bibliografía, hemos querido realizar una revisión algo más exhaustiva sobre este tema contestando a diferentes
  • [Show abstract] [Hide abstract]
    ABSTRACT: Obstructive sleep apnea (OSA) and asthma are highly prevalent respiratory disorders and are frequently co-morbid. Risk factors common to the two diseases include obesity, rhinitis, and gastroesophageal reflux (GER). Observational and experimental evidence implicates airways and systemic inflammation, neuromechanical effects of recurrent upper airway collapse, and asthma-controlling medications (corticosteroids) as additional explanatory factors. Therefore, undiagnosed or inadequately treated OSA may adversely affect control of asthma and vice versa. It is important for clinicians to be vigilant and specifically address weight-control, nasal obstruction, and GER in these populations. Utilizing validated screening instruments to affirm high risk of co-morbid OSA or asthma in persistently symptomatic patients will allow clinicians to cost-effectively test and treat appropriate patients, potentially improving outcomes. While non-invasive ventilation in acute asthma improves outcomes, the role of chronic continuous positive airway pressure (CPAP; the first-line treatment for OSA) in improving long-term asthma control is not known. Future research should focus on the impact of optimal CPAP therapy and adherence on asthma symptoms and outcomes.
    Sleep Medicine Reviews 07/2013; 18(2). DOI:10.1016/j.smrv.2013.04.004 · 9.14 Impact Factor
Show more